The International Trade Commission published notices in the Oct. 9 Federal Register on the following AD/CVD injury, Section 337 patent or other trade proceedings (any notices that warrant a more detailed summary will be in another ITT article):
The Commerce Department published notices in the Federal Register Oct. 9 on the following AD/CV duty proceedings (any notices that announce changes to AD/CV duty rates, scope, affected firms or effective dates will be detailed in another ITT article):
On Sept. 26, the FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
The Foreign-Trade Zones Board issued the following notices on Oct. 9:
The Court of International Trade on Oct. 8 sustained the Commerce Department's scope ruling including importer Printing Textiles' "Canvas Banner Matisse" imports within the scope of the antidumping duty order on artist canvas from China. Judge Timothy Stanceu said Commerce's interpretation of one sentence of the order's scope that is ambiguous "was not per se unreasonable."
CBP issued the following releases on commercial trade and related matters:
A listing of recent Commerce Department antidumping and countervailing duty messages posted on CBP's website Oct. 8, along with the case number(s) and CBP message number, is provided below. The messages are available by searching for the listed CBP message number at CBP's ADCVD Search page.
CBP's Norfolk office has seized over $450,000 in dental supplies lacking country of origin markings, the agency announced Oct. 7. CBP officers seized the most recent shipment Sept. 17. It consisted of nearly 2 million prophy angle cups, and over 1.6 million dental tray covers, assessed at $419,211. Another shipment consisted of nearly 1.8 million dental bibs valued at $35,980 and was seized Aug. 26. Both shipments were headed to the same Baltimore address. “Consumers have the right, under U.S. law, to know where the products they are purchasing are sourced,” said Mark Laria, CBP’s area port director for Norfolk-Newport News, Virginia.
A new report from C4ADS says that although only 4% of Chinese pharmaceuticals are manufactured in Xinjiang province, FDA registrations of companies in the Uyghur region show that imports that should be banned under the Uyghur Forced Labor Prevention Act are happening.
Former Mexican Ambassador to the U.S. Martha Bárcena said that she has been told that the U.S. will not comply with the panel ruling that said that rollup was understood to be part of the automotive rule of origin (see 2403070067), and she said that is undermining USMCA. She said that's because both the Republicans and the Democrats are fighting for the political support of the United Autoworkers and Teamsters. (The autoworkers' union characterizes rollup as watering down the requirement for North American content in vehicles).